ATE325120T1 - Neue verwendung substituierter aminomethylchromane - Google Patents

Neue verwendung substituierter aminomethylchromane

Info

Publication number: ATE325120T1
Authority: AT; Austria
Prior art keywords: new use; substituted aminomethyl; chromanes; aminomethyl chromanes; substituted
Prior art date: 2001-09-19

Application number

AT02767363T

Other languages

English (en)

Inventor

Henning Boettcher

Ralf Devant

Gerd Bartoszyk

Hermann Russ

Frank Weber

Christoph Seyfried

Original Assignee

Merck Patent Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-09-19

Filing date

2002-08-12

Publication date

2006-06-15

2002-08-12 Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh

2006-06-15 Application granted granted Critical

2006-06-15 Publication of ATE325120T1 publication Critical patent/ATE325120T1/de

Links

-1 AMINOMETHYL CHROMANES Chemical class 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs

AT02767363T 2001-09-19 2002-08-12 Neue verwendung substituierter aminomethylchromane ATE325120T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP01122377		2001-09-19

Publications (1)

Publication Number	Publication Date
ATE325120T1 true ATE325120T1 (de)	2006-06-15

Family

ID=8178662

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02767363T ATE325120T1 (de)	2001-09-19	2002-08-12	Neue verwendung substituierter aminomethylchromane

Country Status (25)

Country	Link
US (1)	US7618988B2 (de)
EP (1)	EP1427724B1 (de)
JP (1)	JP4615857B2 (de)
KR (1)	KR100912911B1 (de)
CN (1)	CN100338060C (de)
AR (1)	AR036677A1 (de)
AT (1)	ATE325120T1 (de)
AU (1)	AU2002331229B2 (de)
BR (1)	BR0212555A (de)
CA (1)	CA2460696C (de)
CY (1)	CY1105118T1 (de)
DE (1)	DE60211186T2 (de)
DK (1)	DK1427724T3 (de)
ES (1)	ES2262840T3 (de)
HU (1)	HUP0401910A3 (de)
MX (1)	MXPA04002492A (de)
MY (1)	MY128882A (de)
PE (1)	PE20030428A1 (de)
PL (1)	PL208787B1 (de)
PT (1)	PT1427724E (de)
RU (1)	RU2322443C2 (de)
SI (1)	SI1427724T1 (de)
TW (1)	TWI244391B (de)
WO (1)	WO2003024960A1 (de)
ZA (1)	ZA200402855B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10318690B3 (de) *	2003-04-24	2004-11-11	Merck Patent Gmbh	Verfahren zur Herstellung von Nicotinaldehyden
FR2978916B1 (fr)	2011-08-10	2013-07-26	Servier Lab	Composition pharmaceutique solide pour administration buccale d'agomelatine
CA2870123C (en) *	2012-04-18	2021-02-23	Contera Pharma Aps	Orally available pharmaceutical formulation suitable for improved management of movement disorders
FR3001894A1 (fr)	2013-02-08	2014-08-15	Servier Lab	Composition pharmaceutique solide pour administration buccale d'agomelatine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5767132A (en) *	1980-10-07	1982-04-23	Nippon Steel Corp	Vertical type continuous annealing furnace having independently moving middle partition plate
DE4135474A1 (de) *	1991-10-28	1993-04-29	Bayer Ag	2-aminomethyl-chromane
SI9300097B (en) *	1992-02-27	2001-12-31	Janssen Pharmaceutica Nv	(benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines
PL181385B1 (pl) *	1993-08-19	2001-07-31	Janssen Pharmaceutica Nv	Nowe pochodne dihydrobenzopiranu o wlasciwosciach naczyniozwezajacych, kompozycja farmaceutyczna i sposób wytwarzania pochodnych dihydrobenzopiranu PL PL PL PL PL PL
EP0707007B1 (de) *	1994-10-14	2001-12-12	MERCK PATENT GmbH	ZNS wirksames (R)-(-)-2-[5-(4-Fluorophenyl)-3-pyridylmethylaminomethyl]chroman
US5585388A (en) *	1995-04-07	1996-12-17	Sibia Neurosciences, Inc.	Substituted pyridines useful as modulators of acetylcholine receptors
US5756521A (en) *	1996-04-03	1998-05-26	American Home Products Corporation	Chroman-2-ylmethylamino derivatives
UA73981C2 (en) *	2000-03-10	2005-10-17	Merck Patent Gmbh	(r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit

2002
- 2002-08-12 EP EP02767363A patent/EP1427724B1/de not_active Expired - Lifetime
- 2002-08-12 PL PL369684A patent/PL208787B1/pl not_active IP Right Cessation
- 2002-08-12 HU HU0401910A patent/HUP0401910A3/hu unknown
- 2002-08-12 BR BR0212555-2A patent/BR0212555A/pt not_active IP Right Cessation
- 2002-08-12 PT PT02767363T patent/PT1427724E/pt unknown
- 2002-08-12 AT AT02767363T patent/ATE325120T1/de active
- 2002-08-12 WO PCT/EP2002/009001 patent/WO2003024960A1/en active IP Right Grant
- 2002-08-12 CA CA2460696A patent/CA2460696C/en not_active Expired - Fee Related
- 2002-08-12 US US10/489,960 patent/US7618988B2/en not_active Expired - Fee Related
- 2002-08-12 RU RU2004112190/15A patent/RU2322443C2/ru not_active IP Right Cessation
- 2002-08-12 SI SI200230351T patent/SI1427724T1/sl unknown
- 2002-08-12 CN CNB028183266A patent/CN100338060C/zh not_active Expired - Fee Related
- 2002-08-12 AU AU2002331229A patent/AU2002331229B2/en not_active Ceased
- 2002-08-12 KR KR1020047002484A patent/KR100912911B1/ko not_active IP Right Cessation
- 2002-08-12 DE DE60211186T patent/DE60211186T2/de not_active Expired - Lifetime
- 2002-08-12 MX MXPA04002492A patent/MXPA04002492A/es active IP Right Grant
- 2002-08-12 ES ES02767363T patent/ES2262840T3/es not_active Expired - Lifetime
- 2002-08-12 DK DK02767363T patent/DK1427724T3/da active
- 2002-08-12 JP JP2003528807A patent/JP4615857B2/ja not_active Expired - Fee Related
- 2002-08-13 TW TW091118183A patent/TWI244391B/zh not_active IP Right Cessation
- 2002-09-16 MY MYPI20023438A patent/MY128882A/en unknown
- 2002-09-17 PE PE2002000915A patent/PE20030428A1/es not_active Application Discontinuation
- 2002-09-18 AR ARP020103509A patent/AR036677A1/es unknown
2004
- 2004-04-15 ZA ZA200402855A patent/ZA200402855B/en unknown
2006
- 2006-07-28 CY CY20061101061T patent/CY1105118T1/el unknown

Also Published As

Publication number	Publication date
RU2004112190A (ru)	2005-05-10
AU2002331229B2 (en)	2008-05-15
KR100912911B1 (ko)	2009-08-20
TWI244391B (en)	2005-12-01
MY128882A (en)	2007-02-28
US7618988B2 (en)	2009-11-17
PL369684A1 (en)	2005-05-02
CA2460696C (en)	2011-01-11
JP2005527476A (ja)	2005-09-15
HUP0401910A2 (hu)	2005-01-28
DK1427724T3 (da)	2006-08-21
DE60211186T2 (de)	2007-01-18
AR036677A1 (es)	2004-09-29
EP1427724B1 (de)	2006-05-03
ES2262840T3 (es)	2006-12-01
RU2322443C2 (ru)	2008-04-20
EP1427724A1 (de)	2004-06-16
SI1427724T1 (sl)	2006-10-31
PT1427724E (pt)	2006-09-29
CN1714089A (zh)	2005-12-28
DE60211186D1 (de)	2006-06-08
JP4615857B2 (ja)	2011-01-19
PL208787B1 (pl)	2011-06-30
US20060229339A1 (en)	2006-10-12
KR20040044461A (ko)	2004-05-28
WO2003024960A1 (en)	2003-03-27
ZA200402855B (en)	2005-01-14
BR0212555A (pt)	2004-10-19
CA2460696A1 (en)	2003-03-27
CY1105118T1 (el)	2009-11-04
CN100338060C (zh)	2007-09-19
MXPA04002492A (es)	2004-05-31
PE20030428A1 (es)	2003-05-24
HUP0401910A3 (en)	2011-02-28

Legal Events

Date

Code

Title

Description

2007-03-15

UEP

Publication of translation of european patent specification

Ref document number: 1427724

Country of ref document: EP

Publication	Publication Date	Title
ATE319730T1 (de)	2006-03-15	Neue kristallforme von azithromycin
DE60236226D1 (de)	2010-06-10	Verbesserung der Altersweitsichtigkeit
DK1360169T3 (da)	2007-11-26	Succinatsalt af O-desmethyl-venlafaxin
DE50212455D1 (de)	2008-08-14	Verwendung von Dimerdiolen
NO20041689L (no)	2004-04-23	Substituerte tioacetamider
DE02784674T1 (de)	2005-05-04	Quantifizierung von polypeptiden
DE60120514D1 (de)	2006-07-20	Plektrum
DE60238924D1 (de)	2011-02-24	Abwälzfräser
DK1373228T3 (da)	2008-08-04	Substituerede fluoralkoxyphenylsulfonylurinstoffer
IS6884A (is)	2003-07-24	Aðferðir við að nýta líffræðilegan fjölbreytileika
ATE325120T1 (de)	2006-06-15	Neue verwendung substituierter aminomethylchromane
IS6888A (is)	2003-07-24	Aðferð við meðferð sykursýki af gerð I
DE60208824D1 (de)	2006-04-06	Verbesserungen von elektromechanischen aktuatoren
ATE289604T1 (de)	2005-03-15	Neue phenylpiperazine
DE60226256D1 (de)	2008-06-05	Chronographen-mechanismus
DE50309081D1 (de)	2008-03-13	Neue diketopyrrolopyrrolpigmente
DE60216986D1 (de)	2007-02-01	Neue verwendung von pipatalin
DE60206043D1 (de)	2005-10-13	Neue indolderivate
DE60211158D1 (de)	2006-06-08	Neue verwendung von cyclodextrineinschlusskomplexen
DE50205590D1 (de)	2006-04-06	Ummantelung von leiterbahnen
NO20014168D0 (no)	2001-08-28	Ballastvannutskifting
DE60112036D1 (de)	2005-08-25	Uhrwerk
DE10294298D2 (de)	2004-07-29	Plektron
FI20010391A0 (fi)	2001-02-27	Kalanteri
DE60233601D1 (de)	2009-10-15	Verwendung von bestimmten Cyclolignanen